Drugmaker Regeneron's revenue jumps on Eylea sales
August 04, 2015 at 06:39 AM EDT
Aug 4 (Reuters) - Regeneron Pharmaceuticals Inc reported a 50 percent rise in quarterly revenue, boosted by increasing demand for its blockbuster eye drug, Eylea.
